No Data
No Data
Neurogene CEO Rachel McMinn Acquires $968,999 in Stock
Insider Purchase: President and CFO of $NGNE (NGNE) Buys 24,000 Shares
H.C. Wainwright Maintains Neurogene(NGNE.US) With Buy Rating, Maintains Target Price $55
Neurogene Price Target Maintained With a $55.00/Share by HC Wainwright & Co.
Neurogene Adjusts Clinical Trial After Setback
Express News | Neurogene Shares Shares Down 5.5% After the Bell Following Announcement That Trial Participant Died, FDA Allowing It to Proceed With Trial for Rett Syndrome
No Data
No Data